Acute respiratory distress syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
Acute respiratory distress syndrome is relatively uncommon, occurring in 1.5-13.5 people per 100,000. It can be associated with a number of trigger conditions such as [[sepsis]], [[pulmonary aspiration|aspiration]], and [[pneumonia]]. | Acute respiratory distress syndrome is relatively uncommon, occurring in 1.5-13.5 people per 100,000. It can be associated with a number of trigger conditions such as [[sepsis]], [[pulmonary aspiration|aspiration]], and [[pneumonia]]. | ||
==Epidemiology== | ==Epidemiology and Demographics== | ||
* The annual incidence of ARDS is between 1.5 to 13.5 people per 100,000 in the general population | * The annual incidence of ARDS is between 1.5 to 13.5 people per 100,000 in the general population | ||
* Its incidence in the [[intensive care unit]] (ICU), [[mechanical ventilation|mechanically ventilated]] population is much higher. Brun-Buisson ''et al.'' (2004) reported a prevalence of acute lung injury (ALI) (see below) of 16.1% percent in ventilated patients admitted for more than 4 hours. More than half these patients may develop ARDS. | * Its incidence in the [[intensive care unit]] (ICU), [[mechanical ventilation|mechanically ventilated]] population is much higher. Brun-Buisson ''et al.'' (2004) reported a prevalence of acute lung injury (ALI) (see below) of 16.1% percent in ventilated patients admitted for more than 4 hours. More than half these patients may develop ARDS. | ||
* Mortality varies from 30% to 60%. Usually, [[randomized controlled trials]] in the literature show lower death rates, both in control and treatment patients. This is thought to be due to stricter enrollment criteria. Observational studies generally report 50%-60% mortality. | * Mortality varies from 30% to 60%. Usually, [[randomized controlled trials]] in the literature show lower death rates, both in control and treatment patients. This is thought to be due to stricter enrollment criteria. Observational studies generally report 50%-60% mortality. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Intensive care medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Syndromes]] | |||
[[Category:Overview complete]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 23:52, 24 September 2012
|
Acute respiratory distress syndrome Microchapters |
|
Differentiating Acute respiratory distress syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute respiratory distress syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acute respiratory distress syndrome epidemiology and demographics |
|
FDA on Acute respiratory distress syndrome epidemiology and demographics |
|
CDC on Acute respiratory distress syndrome epidemiology and demographics |
|
Acute respiratory distress syndrome epidemiology and demographics in the news |
|
Blogs on Acute respiratory distress syndrome epidemiology and demographics |
|
Directions to Hospitals Treating Acute respiratory distress syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Acute respiratory distress syndrome is relatively uncommon, occurring in 1.5-13.5 people per 100,000. It can be associated with a number of trigger conditions such as sepsis, aspiration, and pneumonia.
Epidemiology and Demographics
- The annual incidence of ARDS is between 1.5 to 13.5 people per 100,000 in the general population
- Its incidence in the intensive care unit (ICU), mechanically ventilated population is much higher. Brun-Buisson et al. (2004) reported a prevalence of acute lung injury (ALI) (see below) of 16.1% percent in ventilated patients admitted for more than 4 hours. More than half these patients may develop ARDS.
- Mortality varies from 30% to 60%. Usually, randomized controlled trials in the literature show lower death rates, both in control and treatment patients. This is thought to be due to stricter enrollment criteria. Observational studies generally report 50%-60% mortality.